[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340956-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340956-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","benzosceptrin-c-induces-lysosomal-degradation-of-pd-l1-and-promotes-antitumor-immunity-by-targeting-dhhc3","Benzosceptrin C induces lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting DHHC3","","Benzosceptrin C (BC), a natural marine product, reduces the abundance of PD-L1 and thereby enhances the cytotoxicity of T cells against cancer cells. Mechanistic work identifies DHHC3 as the BC target and shows that DHHC3 inhibition prevents PD-L1 palmitoylation, promoting its transfer from membrane to cytoplasm. PD-L1 then undergoes lysosome-mediated degradation and cannot recycle back to the membrane. In MC38 tumor-bearing mice, BC activates tumor-infiltrating T cell immunity and works synergistically with anti-CTLA4 to suppress tumor growth, supporting a novel immune checkpoint blockade strategy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/benzosceptrin-c-induces-lysosomal-degradation-of-pd-l1-and-promotes-antitumor-immunity-by-targeting-dhhc3/340956/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/benzosceptrin-c-induces-lysosomal-degradation-of-pd-l1-and-promotes-antitumor-immunity-by-targeting-dhhc3/340956.png","ImageObject",300,407,{"name":42,"@type":43},"Anda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",17,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does benzosceptrin C address in cancer immunotherapy?","Question",{"text":63,"@type":64},"Benzosceptrin C targets PD-L1, reducing its abundance and thereby strengthening T cell–mediated antitumor responses through an immune checkpoint blockade mechanism.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does benzosceptrin C mechanistically reduce PD-L1 levels?",{"text":68,"@type":64},"BC inhibits DHHC3 enzymatic activity, preventing PD-L1 palmitoylation. This drives PD-L1 from the membrane to the cytoplasm and triggers lysosome-mediated degradation rather than membrane recycling.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the in vivo antitumor effect of benzosceptrin C and how does it combine with other therapy?",{"text":72,"@type":64},"In MC38 tumor-bearing mice, BC activates tumor-infiltrating T cell immunity and enhances antitumor T cell responses. Combined treatment with anti-CTLA4 effectively suppresses tumor growth.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340956,1790149468,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Article  \nBenzosceptrin C induces lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting DHHC3  \nAuthors  \nQun Wang, Jinxin Wang, Dianping Yu, ..., Ang Li, Sanhong Liu, Weidong Zhang  \nCorrespondence  \n[liush@shutcm.edu.cn](liush@shutcm.edu.cn) (S.L.),  \n[wdzhangy@hotmail.com](wdzhangy@hotmail.com) (W.Z.)  \nIn brief  \nWang et al. explored the ability of benzosceptrin C (BC) to reduce PD-L1 expression. Subsequently, DHHC3 wasidentiﬁed as the target protein for BC through methods such as DARTS, CETSA, MST, and molecular docking. BC exerts its antitumor effect on MC38 tumor mice by activating tumor-inﬁltrating T cell immunity.  \nd Benzosceptrin C promotes PD-L1 degradation in a lysosomal pathway  \nd Inhibition of DHHC3 activity destabilizes PD-L1  \nd Benzosceptrin C enhances the cytotoxicity of T cells  \nd Combination of benzosceptrin C and anti-CTLA4 effectively suppresses tumor growth  \nWang et al., 2024, Cell Reports Medicine 5, 101357 February 20, 2024 ª 2023 The Author(s) .  \n[https://doi.org/10.1016/j.xcrm.2023.101357](https://doi.org/10.1016/j.xcrm.2023.101357)  \nll  \nll  \nOPEN ACCESS  \nArticle  \nBenzosceptrin C induces lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting DHHC3  \nQun Wang,1,7 Jinxin Wang,2,7 Dianping Yu,1,7 Qing Zhang,1,7 Hongmei Hu,1 Mengting Xu,1 Hongwei Zhang,1 Saisai Tian,2 Guangyong Zheng,1 Dong Lu,1 Jiajia Hu,3 Mengmeng Guo,1 Minchen Cai,1 Xiangxin Geng,1 Yanyan Zhang,1 Jianhua Xia,1 Xing Zhang,1 Ang Li,4 Sanhong Liu,1,* and Weidong Zhang1,2,5,6,8,*  \n1Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China  \n2Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai, China  \n3Department of Nuclear Medicine, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China  \n4State Key Laboratory of Bioorganic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China  \n5Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China  \n6The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosafety, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China  \n7These authors contributed equally  \n8Lead contact  \n*Correspondence: [liush@shutcm.edu.cn](liush@shutcm.edu.cn) (S.L.), [wdzhangy@hotmail.com](wdzhangy@hotmail.com) (W.Z.) [https://doi.org/10.1016/j.xcrm.2023.101357](https://doi.org/10.1016/j.xcrm.2023.101357)  \nSUMMARY  \nProgrammed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) blockade has become a mainstay of cancer immunotherapy. Targeting the PD-1/PD-L1 axis with small molecules is an attractive approach to enhance antitumor immunity. Here, we identiﬁed a natural marine product, benzosceptrin C (BC), that enhances the cytotoxicity of T cells to cancer cells by reducing the abundance of PD-L1 . Furthermore, BC exerts its antitumor effect in mice bearing MC38 tumors by activating tumor-inﬁltrating T cell immunity. Mechanistic studies suggest that BC can prevent palmitoylation of PD-L1 by inhibiting DHHC3 enzymatic activity. Subsequently, PD-L1 is transferred from the membrane to the cytoplasm and cannot return to the membrane via recycling endosomes, triggering lysosome-mediated degradation of PD-L1 . Moreover, the combination of BC and anti-CTLA4 effectively enhances antitumor T cell immunity. Our ﬁndings reveal a previously unrecognized antitumor mechanism of BC and represent an alternative immune checkpoint blockade (ICB) therapeutic strategy to enhance the efﬁcacy of cancer immunotherapy.  \nINTRODUCTION  \nImmunotherapy is no ","cbCaiuzZj14mOxh0","https://ap.wps.com/l/cbCaiuzZj14mOxh0","pdf",10560076,21,"English","# Summary\n# Introduction","[{\"question\":\"What problem does benzosceptrin C address in cancer immunotherapy?\",\"answer\":\"Benzosceptrin C targets PD-L1, reducing its abundance and thereby strengthening T cell–mediated antitumor responses through an immune checkpoint blockade mechanism.\"},{\"question\":\"How does benzosceptrin C mechanistically reduce PD-L1 levels?\",\"answer\":\"BC inhibits DHHC3 enzymatic activity, preventing PD-L1 palmitoylation. This drives PD-L1 from the membrane to the cytoplasm and triggers lysosome-mediated degradation rather than membrane recycling.\"},{\"question\":\"What is the in vivo antitumor effect of benzosceptrin C and how does it combine with other therapy?\",\"answer\":\"In MC38 tumor-bearing mice, BC activates tumor-infiltrating T cell immunity and enhances antitumor T cell responses. Combined treatment with anti-CTLA4 effectively suppresses tumor growth.\"}]","Benzosceptrin C induces lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting DHHC3 | PDF",1790039683,53,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c0ae9eb0ec72b8a6feba5845c83bc83.webp",983,1276,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a37a9499b9609642f1fe12b68dcb9819.webp",982,1275,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d106495825e3851a2894a0f86a27e18.webp",981,1273,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e9bb29c68d92c7d0b510d1aed8f9ef2.webp",980,1272]